| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
University Of Texas/texas Am Investment Management Co is a 10% Owner at Rein Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 36 sells.
Estimated insider holdings value: $2.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | RNTX Rein Therapeutics, Inc. | 10% Owner | Sell | 6,607 | $3.26 | $21,567.75 | -0.2% | -13.1% | -43.9% | |
| Jun 12, 2024 | RNTX Rein Therapeutics, Inc. | 10% Owner | Sell | 24,671 | $3.27 | $80,709.83 | -0.3% | -15.7% | -39.4% | |
| Jun 7, 2024 | RNTX Rein Therapeutics, Inc. | 10% Owner | Sell | 12,315 | $3.29 | $40,528.30 | -0.1% | -10.8% | -38.3% | |
| May 1, 2024 | RNTX Rein Therapeutics, Inc. | 10% Owner | Sell | 31,151 | $4.47 | $139,102.92 | - | -44.5% | -60.6% |